
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
First Trust Large Cap Value AlphaDEX® Fund (FTA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/01/2025: FTA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 12.22% | Avg. Invested days 47 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) - | Beta 0.99 | 52 Weeks Range 65.75 - 82.70 | Updated Date 06/29/2025 |
52 Weeks Range 65.75 - 82.70 | Updated Date 06/29/2025 |
Upturn AI SWOT
First Trust Large Cap Value AlphaDEX® Fund
ETF Overview
Overview
The First Trust Large Cap Value AlphaDEXu00ae Fund (FDA) is designed to provide investment results that correspond generally to the price and yield of an equity index called the StrataQuantu00ae Value Index. The fund focuses on large-cap U.S. value stocks selected and weighted based on fundamental growth factors.
Reputation and Reliability
First Trust is a well-established ETF provider with a reputation for innovative and rules-based investment strategies.
Management Expertise
First Trust has a dedicated team of investment professionals with experience in quantitative analysis and ETF management.
Investment Objective
Goal
The fund seeks investment results that correspond generally to the price and yield of the StrataQuantu00ae Value Index.
Investment Approach and Strategy
Strategy: The ETF employs a quantitative methodology, the AlphaDEXu00ae stock selection process, to identify and weight value stocks demonstrating superior growth potential.
Composition The ETF holds a diversified portfolio of large-cap U.S. value stocks.
Market Position
Market Share: FDA holds a moderate market share within the large-cap value ETF category.
Total Net Assets (AUM): 1585000000
Competitors
Key Competitors
- VTV
- IWD
- IVE
Competitive Landscape
The large-cap value ETF market is highly competitive, with many well-established funds. FDA's AlphaDEXu00ae strategy provides a differentiated approach, but its higher expense ratio may be a disadvantage compared to lower-cost, passively managed competitors. Advantages include a potentially higher return due to active selection. Disadvantages are higher expenses and possibility of underperforming its benchmark index.
Financial Performance
Historical Performance: Historical performance data is readily available from financial data providers and First Trust's website and should be reviewed to understand the ETFu2019s track record. Return [3.82, 13.52, 9.97, 9.92, 10.82] % for the past 1,3,5,10 year and since inception respectively.
Benchmark Comparison: The ETF's performance should be compared to its benchmark, the StrataQuantu00ae Value Index, and other relevant large-cap value indices like the Russell 1000 Value Index to assess its relative performance.
Expense Ratio: 0.29
Liquidity
Average Trading Volume
FDA's average daily trading volume is adequate, but it may be lower compared to the more popular, passively managed large-cap value ETFs.
Bid-Ask Spread
The bid-ask spread for FDA is typically competitive but may widen during periods of market volatility.
Market Dynamics
Market Environment Factors
Economic indicators, interest rate movements, and value stock performance relative to growth stocks can impact FDA's performance.
Growth Trajectory
The growth trajectory of FDA is tied to the overall performance of the value stock market and the effectiveness of its AlphaDEXu00ae methodology. The ETF dynamically rebalances its holdings, which could impact its performance over time.
Moat and Competitive Advantages
Competitive Edge
FDA's competitive edge lies in its AlphaDEXu00ae methodology, which uses quantitative factors to identify value stocks with strong growth potential. This active selection approach differentiates it from passively managed value ETFs. The fund's focus on fundamental factors aims to improve stock selection. However, this active approach leads to a slightly higher expense ratio, requiring consistent outperformance to justify the cost.
Risk Analysis
Volatility
FDA's volatility is expected to be similar to other large-cap value ETFs, influenced by the volatility of the underlying stocks and broader market conditions.
Market Risk
FDA is subject to market risk, including the risk that its underlying holdings may decline in value due to economic, political, or company-specific factors.
Investor Profile
Ideal Investor Profile
FDA is suitable for investors seeking exposure to large-cap U.S. value stocks with the potential for enhanced returns through active selection. It is appropriate for investors who understand and accept the risks associated with quantitative investment strategies.
Market Risk
FDA is best suited for long-term investors seeking value exposure who are comfortable with a slightly higher expense ratio for a potentially higher return. Not recommended for purely passive index followers.
Summary
The First Trust Large Cap Value AlphaDEXu00ae Fund (FDA) offers exposure to large-cap U.S. value stocks selected using a quantitative AlphaDEXu00ae methodology. It differentiates itself from passively managed funds through its active stock selection and weighting process. While its expense ratio is higher, it aims to deliver enhanced returns through a fundamentally driven approach. The ETF is appropriate for investors seeking value exposure with a tolerance for moderate volatility and a preference for active management.
Peer Comparison
Sources and Disclaimers
Data Sources:
- First Trust Website
- Morningstar
- ETF.com
- Yahoo Finance
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Investment decisions should be based on your own due diligence and consultation with a qualified financial advisor. Market share data is an estimate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About First Trust Large Cap Value AlphaDEX® Fund
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to select value stocks from the NASDAQ US 500 Large Cap Index TM (the base index) that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX® selection methodology.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.